165 related articles for article (PubMed ID: 3891282)
21. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
Tan TH; Tay L; Yeo M; Feng PH
Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
[No Abstract] [Full Text] [Related]
22. Clinical experience with intravenous Augmentin in the treatment of paediatric infections.
Ploechl E; Huber EG
J Int Med Res; 1986; 14(3):153-7. PubMed ID: 3636248
[TBL] [Abstract][Full Text] [Related]
23. Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate.
Thorburn CE; Molesworth SJ; Sutherland R; Rittenhouse S
Antimicrob Agents Chemother; 1996 Dec; 40(12):2796-801. PubMed ID: 9124843
[TBL] [Abstract][Full Text] [Related]
24. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Haruta T; Kuroki S; Okura K; Kobayashi Y
Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
[TBL] [Abstract][Full Text] [Related]
25. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
[TBL] [Abstract][Full Text] [Related]
26. Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.
Aronoff SC; Jacobs MR; Johenning S; Yamabe S
Antimicrob Agents Chemother; 1984 Oct; 26(4):580-2. PubMed ID: 6097169
[TBL] [Abstract][Full Text] [Related]
27. Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.
Leigh DA; Bradnock K; Marriner JM
J Antimicrob Chemother; 1981 Mar; 7(3):229-36. PubMed ID: 6974165
[No Abstract] [Full Text] [Related]
28. In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics.
Focht J; Klietmann W; Heilmann HD
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):523-30. PubMed ID: 6564828
[TBL] [Abstract][Full Text] [Related]
29. Amoxicillin plus clavulanic acid in the treatment of recurrent urinary tract infections.
Brumfitt W; Hamilton-Miller JM
Antimicrob Agents Chemother; 1984 Feb; 25(2):276-8. PubMed ID: 6561953
[TBL] [Abstract][Full Text] [Related]
30. [Clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules on skin and soft tissue infections in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
Jpn J Antibiot; 1985 Feb; 38(2):507-37. PubMed ID: 3892077
[TBL] [Abstract][Full Text] [Related]
31. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
Fomina IP
Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
[No Abstract] [Full Text] [Related]
32. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.
Steingrube VA; Wallace RJ; Brown BA; Pang Y; Zeluff B; Steele LC; Zhang Y
Antimicrob Agents Chemother; 1991 Mar; 35(3):524-8. PubMed ID: 2039203
[TBL] [Abstract][Full Text] [Related]
33. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
Bedenić B; Zagar Z
J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
[TBL] [Abstract][Full Text] [Related]
34. [Experimental and clinical evaluation of the BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
Shinozaki T; Meguro H; Fujii R; Mashiko Z; Okamoto Y; Arimasu O
Jpn J Antibiot; 1985 Feb; 38(2):269-86. PubMed ID: 4009949
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
37. Amoxicillin/clavulanate in urinary tract infection.
Gasser TC; Larsen EH; Madsen PO
Urology; 1987 Jan; 29(1):111-4. PubMed ID: 3541346
[TBL] [Abstract][Full Text] [Related]
38. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
Cunha BA
Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
[TBL] [Abstract][Full Text] [Related]
39. [Tolerance of amoxicillin-clavulanic acid combination in the child].
Tazi-Lakhsassi L; Abid A; Sehlane M
J Int Med Res; 1986; 14(3):158-61. PubMed ID: 3721056
[TBL] [Abstract][Full Text] [Related]
40. [Augmentin: the world-wide experience in its clinical use].
Dutey IV
Antibiot Khimioter; 1992 Sep; 37(9):16-8. PubMed ID: 1444660
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
